Procter & Gamble (NYSE:PG) Releases FY 2022 Earnings Guidance

Procter & Gamble (NYSE:PGGet Rating) issued an update on its FY 2022 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $5.830-$6.000 for the period, compared to the Thomson Reuters consensus estimate of $5.850. The company issued revenue guidance of $79.16 billion-$79.92 billion, compared to the consensus revenue estimate of $79.42 billion.

Shares of NYSE PG opened at $159.41 on Wednesday. Procter & Gamble has a 1-year low of $130.29 and a 1-year high of $165.35. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.67 and a quick ratio of 0.50. The business’s fifty day moving average price is $154.36 and its two-hundred day moving average price is $153.08. The firm has a market capitalization of $385.76 billion, a PE ratio of 28.16, a P/E/G ratio of 4.26 and a beta of 0.46.

Procter & Gamble (NYSE:PGGet Rating) last issued its earnings results on Wednesday, January 19th. The company reported $1.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.01. Procter & Gamble had a return on equity of 31.99% and a net margin of 18.52%. The firm had revenue of $20.95 billion for the quarter, compared to analyst estimates of $20.34 billion. During the same period last year, the company earned $1.64 earnings per share. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. Equities research analysts expect that Procter & Gamble will post 5.87 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, May 16th. Shareholders of record on Friday, April 22nd will be given a $0.9133 dividend. The ex-dividend date of this dividend is Thursday, April 21st. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.87. This represents a $3.65 annualized dividend and a yield of 2.29%. Procter & Gamble’s dividend payout ratio (DPR) is currently 61.48%.

A number of research analysts have recently commented on the company. Raymond James assumed coverage on Procter & Gamble in a report on Thursday, April 7th. They set an outperform rating and a $175.00 price target on the stock. Morgan Stanley raised their price target on Procter & Gamble from $161.00 to $177.00 and gave the company an overweight rating in a report on Thursday, January 20th. Royal Bank of Canada raised their price target on Procter & Gamble from $150.00 to $160.00 and gave the company a sector perform rating in a report on Thursday, January 20th. Truist Financial raised Procter & Gamble from a hold rating to a buy rating and raised their price target for the company from $165.00 to $175.00 in a report on Tuesday, March 22nd. Finally, The Goldman Sachs Group lowered their target price on Procter & Gamble from $179.00 to $173.00 in a report on Tuesday, March 29th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Procter & Gamble has a consensus rating of Hold and an average target price of $161.60.

In other Procter & Gamble news, insider Deborah P. Majoras sold 1,927 shares of the firm’s stock in a transaction dated Tuesday, March 1st. The stock was sold at an average price of $153.51, for a total transaction of $295,813.77. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jon R. Moeller sold 281,271 shares of Procter & Gamble stock in a transaction dated Friday, January 28th. The shares were sold at an average price of $160.58, for a total value of $45,166,497.18. The disclosure for this sale can be found here. Insiders sold a total of 566,796 shares of company stock valued at $91,098,906 in the last quarter. 0.51% of the stock is currently owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in PG. Morgan Stanley lifted its position in shares of Procter & Gamble by 5.0% in the second quarter. Morgan Stanley now owns 34,500,719 shares of the company’s stock valued at $4,655,181,000 after buying an additional 1,632,893 shares during the last quarter. EverSource Wealth Advisors LLC bought a new position in Procter & Gamble during the 4th quarter worth $986,000. OLD Mission Capital LLC bought a new position in Procter & Gamble during the 3rd quarter worth $349,000. Heritage Wealth Advisors increased its stake in Procter & Gamble by 20.9% during the 4th quarter. Heritage Wealth Advisors now owns 10,906 shares of the company’s stock worth $1,784,000 after acquiring an additional 1,883 shares during the period. Finally, Lombard Odier Asset Management USA Corp bought a new position in Procter & Gamble during the 4th quarter worth $281,000. 63.05% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Company Profile (Get Rating)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.